XML 154 R43.htm IDEA: XBRL DOCUMENT v3.24.0.1
Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)
3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Sep. 30, 2023
Finite Lived Intangible Assets [Line Items]      
Net Carrying Amount $ 9,837,000   $ 10,262,000
Amortization expense 400,000 $ 400,000  
Novartis      
Finite Lived Intangible Assets [Line Items]      
Gross Carrying Amount 24,857,000   24,857,000
Accumulated Amortization 15,020,000   14,595,000
Impairment 0   0
Net Carrying Amount 9,837,000   10,262,000
Novartis | Patents      
Finite Lived Intangible Assets [Line Items]      
Gross Carrying Amount 21,728,000   21,728,000
Accumulated Amortization 13,709,000   13,321,000
Impairment 0   0
Net Carrying Amount $ 8,019,000   $ 8,407,000
Useful Lives 14 years   14 years
Novartis | License      
Finite Lived Intangible Assets [Line Items]      
Gross Carrying Amount $ 3,129,000   $ 3,129,000
Accumulated Amortization 1,311,000   1,274,000
Impairment 0   0
Net Carrying Amount $ 1,818,000   $ 1,855,000
Useful Lives 21 years   21 years